Yamada T, Saito N, Imai T, Otagiri M
Pharmaceutical Laboratories, Kissei Pharmaceutical Co., Ltd., Nagano, Japan.
Chem Pharm Bull (Tokyo). 1999 Sep;47(9):1311-3. doi: 10.1248/cpb.47.1311.
A new benzofuroquinoline derivative, 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoli ne-6-one (KCA-098), shows poor oral absorption due to practical insolubility in water. In this study, a co-grinding technique employing a water-soluble polymer was used for improvement of the dissolution rate of KCA-098. Powder X-ray diffraction patterns and IR spectra of KCA-098 showed the conversion of the drug from a crystal state to an amorphous state by grinding with a polymer such as hydroxypropyl cellulose (HPC-SL) or polyvinylpyrrolidone (PVP K30). The particle size of KCA-098 was remarkably reduced to a submicron size by grinding with HPC-SL. The co-ground mixture with HPC-SL showed a rapid dissolution rate and maintained supersaturation for more than 1 h. On the other hand, the co-ground mixture with PVP K30 showed rapid dissolution and supersaturation for a shorter period. These data suggest that the rapid dissolution rate was obtained by the conversion of the drug particles from a crystal to amorphous state by grinding with water-soluble polymers and that a reduction in particle size to the submicron level led to the maintenance of supersaturation due to good dispersion.
一种新型苯并呋喃喹啉衍生物,3,9-双(N,N-二甲基氨甲酰氧基)-5H-苯并呋喃[3,2-c]喹啉-6-酮(KCA-098),由于在水中实际不溶而口服吸收较差。在本研究中,采用一种使用水溶性聚合物的共研磨技术来提高KCA-098的溶解速率。KCA-098的粉末X射线衍射图谱和红外光谱表明,通过与羟丙基纤维素(HPC-SL)或聚乙烯吡咯烷酮(PVP K30)等聚合物研磨,药物从结晶态转变为无定形态。通过与HPC-SL研磨,KCA-098的粒径显著减小至亚微米尺寸。与HPC-SL的共研磨混合物显示出快速的溶解速率,并保持过饱和状态超过1小时。另一方面,与PVP K30的共研磨混合物在较短时间内显示出快速溶解和过饱和。这些数据表明,通过与水溶性聚合物研磨使药物颗粒从结晶态转变为无定形态可获得快速溶解速率,并且将粒径减小至亚微米水平由于良好的分散性而导致过饱和状态的维持。